Treatment of patients with metastatic urothelial cancer “unfit” for cisplatin-based chemotherapy
MD Galsky, NM Hahn, J Rosenberg… - Journal of clinical …, 2011 - ascopubs.org
Purpose Cisplatin-based combination chemotherapy is considered standard first-line
treatment for patients with metastatic urothelial carcinoma. However, a large proportion of …
treatment for patients with metastatic urothelial carcinoma. However, a large proportion of …
[PDF][PDF] Treatment of Patients With Metastatic Urothelial Cancer “Unfit” for Cisplatin-Based Chemotherapy
MD Galsky, NM Hahn, J Rosenberg, G Sonpavde… - J Clin …, 2011 - cccnevada.com
Purpose Cisplatin-based combination chemotherapy is considered standard first-line
treatment for patients with metastatic urothelial carcinoma. However, a large proportion of …
treatment for patients with metastatic urothelial carcinoma. However, a large proportion of …
Treatment of patients with metastatic urothelial cancer" unfit" for Cisplatin-based chemotherapy
MD Galsky, NM Hahn, J Rosenberg… - Journal of clinical …, 2011 - pubmed.ncbi.nlm.nih.gov
Purpose Cisplatin-based combination chemotherapy is considered standard first-line
treatment for patients with metastatic urothelial carcinoma. However, a large proportion of …
treatment for patients with metastatic urothelial carcinoma. However, a large proportion of …
Treatment of Patients With Metastatic Urothelial Cancer “Unfit” for Cisplatin-Based Chemotherapy
MD Galsky, NM Hahn, J Rosenberg… - Journal of Clinical …, 2011 - cir.nii.ac.jp
< jats: sec>< jats: title> Purpose</jats: title>< jats: p> Cisplatin-based combination
chemotherapy is considered standard first-line treatment for patients with metastatic …
chemotherapy is considered standard first-line treatment for patients with metastatic …
Treatment of patients with metastatic urothelial cancer" Unfit" for cisplatin-based chemotherapy
MD Galsky, NM Hahn, J Rosenberg… - Journal of Clinical …, 2011 - pure.johnshopkins.edu
Purpose: Cisplatin-based combination chemotherapy is considered standard first-line
treatment for patients with metastatic urothelial carcinoma. However, a large proportion of …
treatment for patients with metastatic urothelial carcinoma. However, a large proportion of …
[引用][C] Treatment of Patients With Metastatic Urothelial Cancer Unfit for Cisplatin-Based Chemotherapy
MD GALSKY, NM HAHN, J BELLMUNT… - Journal of clinical …, 2011 - pascal-francis.inist.fr
Treatment of Patients With Metastatic Urothelial Cancer Unfit for Cisplatin-Based
Chemotherapy CNRS Inist Pascal-Francis CNRS Pascal and Francis Bibliographic …
Chemotherapy CNRS Inist Pascal-Francis CNRS Pascal and Francis Bibliographic …
[PDF][PDF] Treatment of Patients With Metastatic Urothelial Cancer “Unfit” for Cisplatin-Based Chemotherapy
MD Galsky, NM Hahn, J Rosenberg, G Sonpavde… - J Clin …, 2011 - scholar.archive.org
Purpose Cisplatin-based combination chemotherapy is considered standard first-line
treatment for patients with metastatic urothelial carcinoma. However, a large proportion of …
treatment for patients with metastatic urothelial carcinoma. However, a large proportion of …
Treatment of patients with metastatic urothelial cancer" unfit" for Cisplatin-based chemotherapy.
MD Galsky, NM Hahn, J Rosenberg… - Journal of Clinical …, 2011 - europepmc.org
Purpose Cisplatin-based combination chemotherapy is considered standard first-line
treatment for patients with metastatic urothelial carcinoma. However, a large proportion of …
treatment for patients with metastatic urothelial carcinoma. However, a large proportion of …
[引用][C] Treatment of patient with metastatic urothelial cancer" unfit" for cisplatin-based chemotherapy
G MD - J. Clin. Oncol., 2011 - cir.nii.ac.jp